Clinical Trial Update: Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing personalized versus standard duration of dual antiplatelet therapy and comparing new-generation polymer-free versus biodegradab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Snippet

Sponsor: Federico II University | Conditions: Coronary Artery Disease, Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN